Patents for A61P 39 - General protective or antinoxious agents (19,019)
11/2004
11/17/2004CN1546016A Nanometer preparation of natural vitamin E and its preparation
11/11/2004WO2004096950A1 Antioxidative composition
11/11/2004US20040225123 Substituted phenyl naphthalenes as estrogenic agents
11/11/2004US20040224314 G-protein coupled receptors
11/11/2004DE19718245C5 Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung Synthetic triglycerides based on conjugated linoleic acid, processes for their preparation and their use
11/11/2004CA2847543A1 Annatto extract compositions, including geranyl geraniols and methods of use
11/10/2004EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004EP1474395A1 Nicotinamide derivates useful as p38 inhibitors
11/10/2004EP1474158A2 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
11/10/2004EP1474130A2 Use of compounds and compositions derived from olives for protecting cells against dna damage
11/10/2004EP1207848B1 Purifying and/or regenerating agent
11/10/2004EP1187854B1 Per(3,6-anhydro)cyclodextrin derivatives, preparation and use thereof for separating ions
11/10/2004CN1545418A Method of increasing the presence of glutathione in cells
11/10/2004CN1543939A Ferulaic acid sodium transfusion and prescription and preparation thereof
11/04/2004WO2004076349B1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto
11/04/2004WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004US20040220117 Proteotoxin neutralizer
11/04/2004US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders
11/04/2004US20040219201 Tempamine compositions and methods of use
11/04/2004US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004US20040219114 Cream for treatment of skin injured by the sun
11/03/2004EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004EP1471928A1 Hiv inhibiting proteins
11/03/2004EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004EP1471901A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
11/03/2004EP1471887A2 Nanoparticulate compositions having lysozyme as a surface stabilizer
11/03/2004EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/03/2004CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004CN1173934C N-acetoacetarylamides
11/02/2004US6812221 Immobilization
10/2004
10/28/2004WO2004092179A1 Spiro derivative, production process, and antioxidant
10/28/2004WO2004092163A1 Phenylazole compound, production process, and antioxidant drug
10/28/2004WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004WO2001039723A3 Triazospiro compounds having nociceptin receptor affinity
10/28/2004US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004CA2522266A1 Phenylazole compound, production process therefor and antioxidant
10/27/2004EP1470112A1 Substituted pyridazinones as inhibitors of p38
10/27/2004EP1469882A2 Treatment of ms with goat serum
10/27/2004EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators
10/27/2004EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/27/2004EP1237578A4 Micro-cluster liquids and methods of making and using them
10/27/2004EP1037629B1 Combination of a retinoic acid metabolism blocking agent and a tocophereol
10/27/2004CN1172687C Antifatigue health compsn.
10/26/2004US6809178 Polypeptide for use in the treatment of addison's disease
10/26/2004US6809093 Drug resistance therapy
10/26/2004US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
10/21/2004WO2004089354A2 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them
10/21/2004WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
10/21/2004US20040209957 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke
10/21/2004US20040209870 contain 5-HT ligands used to treat central nervous system disorders
10/21/2004US20040208941 Compositions for removal of toxins
10/21/2004DE202004012807U1 Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden Cosmetic and dermatological compositions with DNA repair enzymes and oligopeptides
10/21/2004DE102004010690A1 Gesundheitsfördernde Zusammensetzungen aus lipidhaltigen Pilzen und Thiocyanaten Health-promoting compositions of lipid-containing mushrooms and thiocyanates
10/20/2004EP1468614A1 Method of improving the growth or the efficiency of feed conversion of an animal and composition for use therein
10/20/2004EP1468019A2 Secreted protein
10/20/2004EP1468018A2 Leptin proteins
10/20/2004EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
10/20/2004EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
10/20/2004EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/19/2004US6805887 Superoxide scavenger and beverage containing such
10/14/2004WO2004087160A1 Treatment of neurological conditions
10/14/2004WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages)
10/14/2004WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives
10/14/2004US20040204617 Solvent extraction to remove free radical of p-benzoquinone (p-benzosemiquinone) from cigarette; purification, crystallization and quantitative analysis
10/14/2004US20040203045 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
10/14/2004US20040202624 Galenical formulation
10/13/2004EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1465642A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
10/13/2004EP1465577A2 Methods for improving the aesthetic appearance of skin
10/13/2004EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application
10/13/2004EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/13/2004CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method
10/13/2004CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum
10/13/2004CN1536990A Pharmaceutical composition comprising (-)-secoisolariciresinol
10/13/2004CN1170587C I (Robinia Pseudoacacia) lectin and its uses
10/13/2004CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid
10/07/2004WO2004084916A1 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria
10/07/2004WO2004084914A1 Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals
10/07/2004WO2004084906A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
10/07/2004WO2004084895A2 Modulation of cell death
10/07/2004WO2004084876A2 Use of compounds for the prevention of drug-induced cell toxicity
10/07/2004WO2004071639A3 Per (3,6-anhydro) cyclodextrine derivatives, production and use thereof in transporting metal elements to biological targets or in order to decontaminate biological fluids or targets
10/07/2004US20040198841 Pretreatment before chemotherapy; antiulcer agents for cancer therapy
10/07/2004US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/07/2004US20040198738 Preventives or remedies for diseaes caused by enos expression
10/07/2004US20040198673 Composition for epigallocatechin gallate
10/07/2004CA2560522A1 Use of compounds for the prevention of drug-induced cell toxicity
10/07/2004CA2520403A1 Modulation of cell death
10/06/2004EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004EP1463756A2 Secreted proteins
10/06/2004EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004EP1309309B1 Dermatological composition
10/06/2004EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004CN1533776A Application of N-acetly glucosamine in the preparation of medicine for treating local injury and full body syndrome due to virus or bacterial infestation
10/06/2004CN1533775A Application of N-acetylglucosamine in the preparation of medicine for treating viscera injure due to toxication from poison and medicine